Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women

Muhammad Faisal Aslam,Zaher Merhi,Safaa Ahmed,Oumar Kuzbari,David B. Seifer,Howard Minkoff

Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women

2011

Muhammad Faisal Aslam
Zaher Merhi
Safaa Ahmed
Oumar Kuzbari
David B. Seifer
Howard Minkoff

Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and mullerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.

Keywords:

Neurotrophic factors
Young adult
Anti-Müllerian hormone
Cancer
Brain-derived neurotrophic factor
MULLERIAN-INHIBITING SUBSTANCE
Endocrinology
Ovarian reserve
Internal medicine
Chemotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations